- Source : Press Release
- Date : 2021-07-08
- Companies : Merck KGaA
Merck Appoints Renee Connolly as Chief Diversity Equity & Inclusion Officer
Darmstadt, Germany, July 8, 2021 – Merck, a leading science and technology company, today announced that Renee Connolly has been appointed Chief Diversity Equity & Inclusion (DE&I) Officer, effective August 1. She will take over from Jennifer O’Lear, who will pursue new opportunities within Merck, and become a member of the company’s Human Resources leadership team.
“Diversity, equity and inclusion are core to our culture and an essential part of our innovation and business priorities. We aim to accelerate and broaden our DE&I efforts to create an environment where every Merck employee can grow and develop”, said Belén Garijo, Chair of the Executive Board and CEO of Merck. “Renee Connolly will provide global leadership to advancing our DE&I strategy to deliver on our future ambitions.”
Connolly has been with Merck for more than 17 years and served as Head of Communications for the company’s Life Science business sector since 2013. She is a U.S. citizen and will continue to be based in Burlington, Massachusetts, United States.
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.